The Bitter End: The Ubiquitin-Proteasome System and Cardiac Dysfunction
暂无分享,去创建一个
[1] S. Vatner,et al. Activation of the Cardiac Proteasome During Pressure Overload Promotes Ventricular Hypertrophy , 2006, Circulation.
[2] C. Patterson,et al. Into the heart: the emerging role of the ubiquitin-proteasome system. , 2006, Journal of molecular and cellular cardiology.
[3] D. Castrillon,et al. Foxo Transcription Factors Blunt Cardiac Hypertrophy by Inhibiting Calcineurin Signaling , 2006, Circulation.
[4] Peipei Ping,et al. Regulation of Murine Cardiac 20S Proteasomes: Role of Associating Partners , 2006, Circulation research.
[5] P. Ping,et al. Mapping the Murine Cardiac 26S Proteasome Complexes , 2006, Circulation research.
[6] C. Fan,et al. Sequential Quality-Control Checkpoints Triage Misfolded Cystic Fibrosis Transmembrane Conductance Regulator , 2006, Cell.
[7] E. Masliah,et al. Prion-Induced Amyloid Heart Disease with High Blood Infectivity in Transgenic Mice , 2006, Science.
[8] Hui-Yan Li,et al. MDM2 interacts with and downregulates a sarcomeric protein, TCAP. , 2006, Biochemical and biophysical research communications.
[9] P. Razeghi,et al. Atrophy, hypertrophy, and hypoxemia induce transcriptional regulators of the ubiquitin proteasome system in the rat heart. , 2006, Biochemical and biophysical research communications.
[10] Jinbao Liu,et al. Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. , 2006, Journal of molecular and cellular cardiology.
[11] Holly McDonough,et al. CHIP-mediated stress recovery by sequential ubiquitination of substrates and Hsp70 , 2006, Nature.
[12] M. Hori,et al. Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice. , 2006, Biochemical and biophysical research communications.
[13] L. Qin,et al. Differential Regulation of Cardiomyocyte Survival and Hypertrophy by MDM2, an E3 Ubiquitin Ligase* , 2006, Journal of Biological Chemistry.
[14] Holly McDonough,et al. Reduced Apaf-1 levels in cardiomyocytes engage strict regulation of apoptosis by endogenous XIAP , 2005, The Journal of cell biology.
[15] E. Murphy,et al. Mitochondrial Dysfunction and Apoptosis Underlie the Pathogenic Process in α-B-Crystallin Desmin-Related Cardiomyopathy , 2005, Circulation.
[16] R. Kayed,et al. Reversal of amyloid-induced heart disease in desmin-related cardiomyopathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] Thomas Sejersen,et al. The Kinase Domain of Titin Controls Muscle Gene Expression and Protein Turnover , 2005, Science.
[18] L. Michael,et al. CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. , 2005, American journal of physiology. Heart and circulatory physiology.
[19] K. Lindenberg,et al. Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants. , 2005, Cardiovascular research.
[20] E. Bennett,et al. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. , 2005, Molecular cell.
[21] Holly McDonough,et al. Muscle ring finger protein-1 inhibits PKCε activation and prevents cardiomyocyte hypertrophy , 2004, The Journal of cell biology.
[22] Cam Patterson,et al. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] Da-Zhi Wang,et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. , 2004, The Journal of clinical investigation.
[24] G. Yancopoulos,et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. , 2004, Molecular cell.
[25] Yi-Ping Li,et al. Atrophic Remodeling of the Heart In Vivo Simultaneously Activates Pathways of Protein Synthesis and Degradation , 2003, Circulation.
[26] V. Godfrey,et al. CHIP activates HSF1 and confers protection against apoptosis and cellular stress , 2003, The EMBO journal.
[27] J. Schaper,et al. Progression From Compensated Hypertrophy to Failure in the Pressure-Overloaded Human Heart: Structural Deterioration and Compensatory Mechanisms , 2003, Circulation.
[28] Michael J Dunn,et al. Hyperubiquitination of proteins in dilated cardiomyopathy , 2003, Proteomics.
[29] Cam Patterson,et al. Welcome to the machine: a cardiologist's introduction to protein folding and degradation. , 2002, Circulation.
[30] K. Fischbeck,et al. Toxic Proteins in Neurodegenerative Disease , 2002, Science.
[31] P. Kloetzel,et al. Inhibition of the ubiquitin-proteasome pathway induces differential heat-shock protein response in cardiomyocytes and renders early cardiac protection. , 2002, Biochemical and biophysical research communications.
[32] Cam Patterson,et al. A New Gun in Town: The U Box Is a Ubiquitin Ligase Domain , 2002, Science's STKE.
[33] B. Friguet,et al. Age-dependent declines in proteasome activity in the heart. , 2002, Archives of biochemistry and biophysics.
[34] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Cyr,et al. CHIP Is a U-box-dependent E3 Ubiquitin Ligase , 2001, The Journal of Biological Chemistry.
[36] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[37] T. Hewett,et al. Expression of R120G–αB-Crystallin Causes Aberrant Desmin and αB-Crystallin Aggregation and Cardiomyopathy in Mice , 2001 .
[38] G. Dorn,et al. Mouse Model of Desmin-Related Cardiomyopathy , 2001, Circulation.
[39] K. Pelin,et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. , 2001, Journal of molecular biology.
[40] E. Olson,et al. Regulation of Microtubule Dynamics and Myogenic Differentiation by Murf, a Striated Muscle Ring-Finger Protein , 2000, The Journal of cell biology.
[41] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.
[42] M. Dalakas,et al. Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene. , 2000, The New England journal of medicine.
[43] S. Gottesman,et al. Posttranslational quality control: folding, refolding, and degrading proteins. , 1999, Science.
[44] S. Jentsch,et al. A Novel Ubiquitination Factor, E4, Is Involved in Multiubiquitin Chain Assembly , 1999, Cell.
[45] M. Prevost,et al. A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy , 1998, Nature Genetics.
[46] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[47] Lawrence A. Donehower,et al. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53 , 1995, Nature.
[48] R. Mestril,et al. Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischemia-induced injury. , 1994, The Journal of clinical investigation.
[49] C. Delcayre,et al. Storage of phosphorylated desmin in a familial myopathy , 1988, FEBS letters.
[50] A. Samarel,et al. Protein synthesis and degradation during starvation-induced cardiac atrophy in rabbits. , 1987, Circulation research.
[51] T. Hewett,et al. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. , 2001, Circulation research.
[52] M J Dunn,et al. Bovine dilated cardiomyopathy: Proteomic analysis of an animal model of human dilated cardiomyopathy , 1999, Electrophoresis.